בייאטה 10 מק"ג

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

EXENATIDE 250 MCG/ML

Dostupné s:

ASTRA ZENECA ISRAEL LTD

ATC kód:

A10BX04

Léková forma:

SOLUTION FOR INJECTION

Podání:

S.C

Výrobce:

LILLY PHARMA FERT. & DISTRIB. GmbH & Co. KG

Terapeutické skupiny:

EXENATIDE

Terapeutické indikace:

Byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.Byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

Datum autorizace:

2013-01-01